Cover Image
QR Code

Emerging and anticipated innovations in prostate cancer MRI and their impact on patient care.

Prostate cancer (PCa) remains the leading malignancy affecting men, with over 3 million men living with the disease in the US, and an estimated 288,000 new cases and almost 35,000 deaths in 2023 in the United States alone. Over the last few decades, imaging has been a cornerstone in PCa care, with a...

Full description

Published in:Abdominal Radiology Vol. 49; no. 10; pp. 3696 - 3711
Main Authors: Correia, Eduardo Thadeu de Oliveira, Baydoun, Atallah, Li, Qiubai, Costa, Daniel N., Bittencourt, Leonardo Kayat
Format: Journal Article
Published: Springer Nature Oct2024
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=179574381&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 179574381
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        2366004X
        JT14
      jtl: Abdominal Radiology
      issn: 2366004X
      maglogo: N
    pubinfo:
      dt: Oct2024
      vid: 49
      iid: 10
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        179574381
        177837318
        10.1007/s00261-024-04423-4
        179574381
      ppf: 3696
      ppct: 15
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Emerging and anticipated innovations in prostate cancer MRI and their impact on patient care.
      aug:
        au:
          Correia, Eduardo Thadeu de Oliveira
          Baydoun, Atallah
          Li, Qiubai
          Costa, Daniel N.
          Bittencourt, Leonardo Kayat
        affil: Department of Radiology, University Hospitals Cleveland Medical Center, Cleveland, OH, USA
      sug:
      ab: Prostate cancer (PCa) remains the leading malignancy affecting men, with over 3 million men living with the disease in the US, and an estimated 288,000 new cases and almost 35,000 deaths in 2023 in the United States alone. Over the last few decades, imaging has been a cornerstone in PCa care, with a crucial role in the detection, staging, and assessment of PCa recurrence or by guiding diagnostic or therapeutic interventions. To improve diagnostic accuracy and outcomes in PCa care, remarkable advancements have been made to different imaging modalities in recent years. This paper focuses on reviewing the main innovations in the field of PCa magnetic resonance imaging, including MRI protocols, MRI-guided procedural interventions, artificial intelligence algorithms and positron emission tomography, which may impact PCa care in the future.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N